Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-907-1 | CAS number: 111-78-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1996
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Guideline study with acceptable restrictions: (1) Both sexes were not evaluated and (2) bone marrow smears were not prepared at more than 1 time point after the multiple exposure regimen.
Data source
Reference
- Reference Type:
- publication
- Title:
- Robust summary and test plan for 1,5-cyclooctadiene with cover letter dated 11 Dec 2002
- Author:
- DuPont Safety, Health & Environmental Excellence Center, Wilmington (Del., USA)
- Year:
- 2 002
- Bibliographic source:
- Quelle U.S. EPA 37 pp
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Principles of method if other than guideline:
- Method: Based on OECD Guideline 474 (1983), EPA Guideline 40 CFR 798.5935, and others
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Cycloocta-1,5-diene
- EC Number:
- 203-907-1
- EC Name:
- Cycloocta-1,5-diene
- Cas Number:
- 111-78-4
- Molecular formula:
- C8H12
- IUPAC Name:
- (1Z,5Z)-cycloocta-1,5-diene
- Details on test material:
- 1,5-cyclooctadiene, purity >99%
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ORGANISMS:
- rats Crl:CD(R)(SD)BR
- Age: 52-53 days
- Weight at study initiation: 229.2-246.8 g
- No. of animals per dose: 10 exposed, 5 per control group
Administration / exposure
- Route of administration:
- inhalation
- Vehicle:
- air
- Details on exposure:
- TYPE OF INHALATION EXPOSURE: - whole body exposure
GENERATION OF TEST ATMOSPHERE
- Vapor atmospheres were generated by metering the liquid test substance into a heated flask with a syringe infusion pump
- atmospheric concentration was determined by gas chromatography
EXAMINATIONS:
- Clinical observations: yes - Duration of treatment / exposure:
- 6 hours/day for 2 consecutive days
- Frequency of treatment:
- 2 consecutive days
- Post exposure period:
- 24 hours
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0 or 1500 ppm (6750 mg/m3)
Basis:
- No. of animals per sex per dose:
- 10 exposed, 5 per control group
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- positive control cyclophosphamide, exposure only on day 2
Examinations
- Tissues and cell types examined:
- polychromatic erythrocytes of the bone marrow from femur
- Details of tissue and slide preparation:
- ADMINISTRATION:
- Duration of test: Sacrifice on day 3, approximately 24 hours after the end of the second exposure
- Sampling times and number of samples: Immediately after sacrifice, marrow from 1 femur of each rat was aspirated, prepared, and at least 2
slides per animal were prepared, fixed, and stained in acridine orange. Prior to scoring, a coverslip was floated on each slide.
- Control groups and treatment:
negative control air,
positive control cyclophosphamide, exposure only on day 2 - Evaluation criteria:
- Criteria for evaluating results: statistically significant and biologically relevant increase in frequency of micronucleated polychromatic
erythrocytes of the test group as compared to the negative control group - Statistics:
- Data for the proportion of MNPCEs among 2000 PCEs and the proportion of PCEs among 1000 erythrocytes were transformed prior to analysis using
the arcsine square root funktion. Transformed data were analyzed separatelyfor normality of distribution and equal variance using the Shapiro-Wilk and Bartlett's tests.
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- MORTALITY:
No test substance-induced mortality was observed.
CLINICAL SIGNS:
Depression or absence of an alerting response mainly during the latter half of the exposures; incoordination was evident in
3/10 rats during the first exposure and in all treated rats after this first exposure. 2/10 rats exhibited abnormal gait after the second exposure.
Irregular respiration was observed in 6/10 rats after the first exposure and in 3/10 rats after the second exposure.
BODY WEIGHT CHANGES:
Losses in 9/10 rats after the first exposure and in all rats after the second exposure.
EFFECT ON MITOTIC INDEX OR PCE/NCE RATIO:
No statistically significant increase in the frequency of micronucleated PCEs was observed in treated rats. A statistically significant depression in the proportion of PCEs among 1000 erythrocytes was observed in the treatment group, indicative of testsubstance-induced bone marrow toxicity. A
statistically significant increase in MNPCE frequency was found in the positive control rats.
Any other information on results incl. tables
no further remarks
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
Under the conditions of this in vivo study 1,5-cyclooctadiene did not induce micronucleated polychromatic erythrocytes in male rats. - Executive summary:
In this in vivo rat micronucleus test 10 male rats were exposed for 6 hours/day for 2 consecutive days to 1500 ppm 1,5-cyclooctadiene.
5 male rats were exposed to the negative control (air). Bone marrow polychromatic erythrocytes, collected 24 hours after the last
exposure, were examined microscopically for micronucleated polychromatic erythrocytes (PCE).
No statistically significant increase in the frequency of micronucleated PCE's was observed in treated rats. A statistically significant depression in the proportion of PCEs among 1000 erythrocytes was observed in the treatment group, indicative
of testsubstance-induced bone marrow toxicity. A statistically significant increase in MNPCE frequency was found in the positive
control rats.
Under the conditions of this in vivo study 1,5-cyclooctadiene did not induce micronucleated polychromatic erythrocytes in male rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.